Patents Assigned to Cancer Research Tecnology Limited
  • GENERATION OF A CANCER-SPECIFIC IMMUNE RESPONSE TOWARD MUC1 AND CANCER SPECIFIC MUC1 ANTIBODIES
    Publication number: 20100034825
    Abstract: The present invention provides a method for inducing a cancer specific immune response against MUC1 using an immunogenic glycopeptide. Other aspects of the invention are a pharmaceutical composition comprising the immunogenic glycopeptide and a cancer vaccine comprising the immunogenic glycopeptide. Another aspect is an antibody generated using the immunogenic glycopeptide and the use of said antibody in therapy and diagnosis.
    Type: Application
    Filed: October 4, 2007
    Publication date: February 11, 2010
    Applicants: Kobenhavns Universitet, Cancer Research Tecnology Limited
    Inventors: Henrik Clausen, Joy Burchell, Ulla Mandel, Anne Louise Sorensen, Mads Agervig Tarp, Joyce Taylor-Papadimitriou